Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
Episodes 181-195 of 469
Innovations in Adherence: Long-Acting Agents for Infectious Diseases
Clinician's RoundtableInnovations in Adherence: Long-Acting Agents for Infectious Diseases
Promising results for self-expanding TAVR device in trial with mostly women
ACC Action CenterPromising results for self-expanding TAVR device in trial with mostly women
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
ACC Action CenterAngiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Climate Change and Neurological Infections: The Effects Over Time
NeuroFrontiersClimate Change and Neurological Infections: The Effects Over Time
Preventive PCI versus optimal medical therapy only for vulnerable plaques
ACC Action CenterPreventive PCI versus optimal medical therapy only for vulnerable plaques
Uncovering a Potential Biomarker for Myasthenia Gravis
NeuroFrontiersUncovering a Potential Biomarker for Myasthenia Gravis
- advertisement
Maternal Stroke: Causes, Risks, and Care in Pregnancy and Postpartum
NeuroFrontiersMaternal Stroke: Causes, Risks, and Care in Pregnancy and Postpartum
Managing Internal Medicine Issues in Hospitalized Neurological Patients
NeuroFrontiersManaging Internal Medicine Issues in Hospitalized Neurological Patients
Recognizing and Addressing Medical Gaslighting in Healthcare
NeuroFrontiersRecognizing and Addressing Medical Gaslighting in Healthcare
Promising results for APOC3 ASO in familial chylomicronemia syndrome
ACC Action CenterPromising results for APOC3 ASO in familial chylomicronemia syndrome
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
ACC Action CenterIncreasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Self-assessment on statin eligibility without prescription using a web app
ACC Action CenterSelf-assessment on statin eligibility without prescription using a web app
- advertisement
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
ACC Action CenterMore than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
Stopping aspirin after 1 month DAPT in ACS patients after stenting
ACC Action CenterStopping aspirin after 1 month DAPT in ACS patients after stenting
Head-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
ACC Action CenterHead-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli

















































